A Comparative Study between the Efficacy of Intratympanic Steroid Injection and Conventional Medical Treatment in Resistant Cases of Otitis Media with Effusion
Article Sidebar
Main Article Content
Abstract
Introduction
Otitis media with effusion (OME) is a multifactorial disease and the treatment options for it are limited and controversial. The aim of the present study was to compare the efficacy of intratympanic steroid injection and conventional medical treatment in resistant cases of OME with hearing loss.
Materials and Methods
A comparative study was conducted among 20 patients of OME with hearing loss, resistant to conventional medical treatment between December 2019 to November 2020. ‘Intratympanic dexamethasone injection’ (ITDI) was given every week for 3 consecutive weeks to one group and the other group continued to receive medical treatment. Hearing was assessed by performing pure tone audiogram before every ITDI and also at 12 weeks follow up after completion of treatment.
Results
Hearing improvement was found to be better in the group which received ITDI (Mean AC-PTA hearing gain = 22.88 dB) than the group where conventional medical treatment was continued (Mean AC-PTA hearing gain = 6.83 dB).
Conclusion
Intratympanic dexamethasone injection has significantly better outcome in term of improvement of hearing loss in resistant cases of OME than conventional medical management, and is an effective and safe therapy.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Arola M, Ziegler T, Lehtonen O-P, Puhakka H, Ruuskanen O. Rhinovirus in otitis media with effusion. Ann Otol Rhinol Laryngol. 1990; 99 (6 I):451-3
Bluestone CD, Gates GA, Klein JO, Lim DJ, Mogi G, Ogra PL et al. Recent advances in otitis media. Panel reports.1.Definitions, terminology, and classification of otitis media. Ann Otol Rhinol Laryngol. 2002; 111:8-18
Ovesen T, Borglum JD. Superoxide dismutase in middle ear fluid from children with secretory otitis media. Acta Otolaryngol. 1992; 112:1017-24
Kumari MS, Madhavi J, Krishna NB, Meghanadh KR, Jyothy A. Prevalence and associated risk factors of otitis media and its subtypes in South Indian population. Egypt J Ear, Nose, Throat Allied Sci. 2016;17:57-62
Yousaf M, Inayatullah, Khan F. Medical versus surgical management of otitis media with effusion in children. J Ayub Med Coll Abbottabad 2012; 24(1):83-5
Kuo CL,Wang MC, Chu CH, Shiao AS. New therapeutic strategy for treating otitis media with effusion in post irradiated nasopharyngeal carcinoma patients. J Chin Med Assoc. 2012; 75(7):329-34
Prokopakis EP, Lachanas VA, Christodoulou PN, Bizakis JG, Karatzanis AD, Velegrakis GA. Implications of laser assisted tympanostomy in adults. Otol Neurotol. 2005; 26(3):361-3
Sedlmaier B, Jivanjee A, Gutzler R, Huscher D, Jovanovic S. Ventilation time of the middle ear in otitis media with effusion (OME) after CO2 laser myringotomy. Laryngoscope 2002; 112(4):661-8
Silverstein H, Light JP, Jackson LE, Rosenberg SI, Thompson JH Jr. Direct application of dexamethasone for the treatment of chronic Eustachian tube dysfunction. Ear Nose Throat J 2003; 82:28-32
Ho WK, Wei WI, Yuen AP, Hui Y,Wong SH. Otorrhea after grommet insertion for middle ear effusion in patients with nasopharyngeal carcinoma. Am J Otolaryngol.1999; 20(1):12-5
Hwang CF, Chien CY, Lin HC, Peng JP, Chang HW, Su CY. Laser myringotomy for otitis media with effusion in nasopharyngeal carcinoma patients. Otolaryngol Head Neck Surg. 2005;132(6):924-7
Tang NL, Choy AT, John DG, van Hasselt CA. The otological status of patients with nasopharyngeal carcinoma after megavoltage radiotherapy. J Laryngol Otol. 1992;106(12):1055-8
Naganawa S, Satake H, Iwano S, Fukatsu H, Sone M, Nakashima T. Imaging endolymphatic hydrops at 3 tesla using 3D-FLAIR with intratympanic Gd-DTPA administration. Magn Reson Med Sci. 2008;7(2):85-91
Cutler JL, Wall M, Labadie RF. Effects of ototopic steroid and NSAIDS in clearing middle ear effusion in an animal model. Otolaryngol Head Neck Surg. 2006; 135(4):585-9
Roland PS, Anon JB, Moe RD, Conroy PJ, Wall GM, Dupre SJ et al. Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in paediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Laryngoscope 2003; 113:2116-22
Han Z, Zhibin C, Dengyuan W, Xia X, Xiaonian Z, Guangqian X. The therapeutic effects of oral administration and intratympanic injection of glucocorticoid in the treatment of otitis media with effusion. Journal of Audiology and Speech Pathology 2009;17(6):560‐2
Paksoy M, Altin G, Eken M, Hardal U. Effectiveness of intratympanic dexamethasone in otitis media with effusion resistant to conventional therapy. Indian J Otolaryngol Head Neck Surg. 2013; 65(Suppl 3):461-7 doi:10.1007/s12070-011-0281-z
Florea A, Zwart JE, Lee CW, Depew A, Park SK, Inman J et al. Effect of topical dexamethasone versus rimexolone on middle ear inflammation in experimental otitis media with effusion. Acta Otolaryngol. 2006;126(9):910-5. doi: 10.1080/00016480600606699
Datema FR, Vemer-van den Hoek JG, Wieringa MH, Mulder PM, Baatenburg de Jong RJ, Blom HM. A visual analog scale can assess the effect of surgical treatment in children with chronic otitis media with effusion. Int J Pediatr Otorhinolryngol. 2008; 72(4):461-7. doi:10.1016/j.ijporl.2007.12.004
Francis NA, Cannings- John R, Waldron CA. Oral steroids for resolution of otitis media with effusion in children (OSTRICH); a double blinded, placebo-controlled randomized trial. Lancet 2018; 392:557-68.